THE MEDULLIPIN SYSTEM OF BLOOD-PRESSURE CONTROL

被引：26

作者：

MUIRHEAD, EE

机构：

[1] The Departments of Pathology, The University of Tennessee, Memphis and Baptist Memorial Hospital, Memphis

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1991年 / 4卷 / 10期

关键词：

RENOMEDULLARY INTERSTITIAL CELLS; MEDULLIPIN-I AND MEDULLIPIN-II; 1-KIDNEY; 1-CLIP HYPERTENSION; LIVER; CYTOCHROME P-450;

D O I：

10.1093/ajh/4.10.556S

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

The medullipin system of BP control has its cellular component in the renomedullary interstitial cells (RICs) of the renal papilla. The RICs secrete medullipin I which is conveyed to the liver to be activated into Med II. This activation appears to involve the cytochrome P-450 dependent enzyme system of the liver. Med II is a vasodilator that suppresses sympathetic tone, causes diuresis-natriuresis and has a suppressive effect on the central nervous system (CNS). As such, Med II has biologic actions the exact opposite of major actions of the renin-angiotensin system. Angiotensin II is a vasoconstrictor that facilitates sympathetic tone, causes salt water retention by the kidney and has stimulatory effect on the CNS. These are double feedback BP control systems. One elevates the BP and is prohypertensive; the other lowers BP and is antihypertensive. Unclipped (UC) the one-kidney, one-clip hypertensive rat has assisted greatly in elucidating the medullipin system. The support for these contentions are documented in this presentation.

引用

页码：S556 / S568

页数：13

共 58 条

[1]

Muirhead E.E., Rightsel W.A., Leach B.E., Et al., Reversal of hypertension by transplants and lipid extracts of cultured renomedullary interstitial cells, Lab Invest, 35, 2, pp. 162-172, (1977)

[2]

Muirhead E.E., Byers L.W., Brooks B., Conversion of the antihypertensive neutral renomedullary lipid by the liver, Trans Assoc am Physicians, 98, pp. 269-274, (1986)

[3]

Muirhead E.E., Brooks B., Byers L.W., Et al., Conversion of medullipin I by the liver, Trans Assoc am Physicians, pp. 226-234, (1988)

[4]

Dundore R.L., Soltis E.E., Shaffer R.A., Et al., Antihypertensive and hemodynamic effects of antihypertensive neutral renomedullary lipid and two synthetic lipids, Snyder lipid and selachyl alcohol (Abst), FASEB J, 2, (1988)

[5]

Muirhead E.E., Folkow B., Byers L.W., Et al., Cardiovascular effects of antihypertensive renomedullary lipids (APRL and ANRL), Acta Physiol Scan, 117, pp. 465-467, (1983)

[6]

Karlstrom G., Amman V., Folkow B., Gothberg G., Activation of the humoral antihypertensive system of the kidney increases diuresis, Hypertension, 11, pp. 597-601, (1988)

[7]

Amman Bergstrom G.V.G., Et al., Renal and circulatory effects of medullipin I as studied in the in vitro cross-circulated isolated kidney and intact Wistar-Kyato (WKY) rat, Acta Physiol Scand, 137, pp. 521-533, (1989)

[8]

Muirhead E.E., Pitcock J.A., The renal antihypertensive hormone, J Hyperten, 3, pp. 1-8, (1985)

[9]

Muirhead E.E., Brooks B., Reversal of one-kidney, one-clip hypertension by unclipping: The renal, sodium-volume relationship re-examined, Proc Soc Exp Biol Med, 163, pp. 540-546, (1980)

[10]

Bing R.F., Russell G.I., Swales J.D., Et al., Chemical renal medullectomy: Effect upon reversal of two-kidney, one-clip hypertension in the rat, Clin Sci, 61, pp. 335-338, (1981)

← 1 2 3 4 5 6 →